BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11293442)

  • 1. Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's disease.
    Arnott ID; Drummond HE; Ghosh S
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):239-43. PubMed ID: 11293442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole gut lavage fluid interleukin-1beta and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remission.
    Arnott ID; Williams N; Drummond HE; Ghosh S
    Dig Liver Dis; 2002 Jun; 34(6):424-9. PubMed ID: 12132790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminal neutrophil migration in ileoanal pouches studied by whole gut lavage.
    Evgenikos NL; Bartolo DC; Hamer-Hodges DW; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):553-7. PubMed ID: 10833100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole-gut lavage fluid.
    Handy LM; Ghosh S; Ferguson A
    Scand J Gastroenterol; 1996 Jul; 31(7):700-5. PubMed ID: 8819221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease.
    Mitsuyama K; Toyonaga A; Sasaki E; Watanabe K; Tateishi H; Nishiyama T; Saiki T; Ikeda H; Tsuruta O; Tanikawa K
    Clin Exp Immunol; 1994 Jun; 96(3):432-6. PubMed ID: 8004812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease.
    Arnott ID; Drummond HE; Ghosh S
    Dig Dis Sci; 2001 Feb; 46(2):402-9. PubMed ID: 11281191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.
    Troncone R; Caputo N; Campanozzi A; Cucciardi M; Esposito V; Russo R; De Vizia B; Greco L; Cucchiara S
    Gut; 1997 Jul; 41(1):60-5. PubMed ID: 9274473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of neutrophil migration into the gut by cytology of whole gut lavage fluid.
    Handy LM; Ghosh S; Ferguson A
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):53-8. PubMed ID: 7866812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.
    Teahon K; Bjarnason I
    Gut; 1993 Nov; 34(11):1535-8. PubMed ID: 8244139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte elastase and systemic cytokine response after laparoscopic-assisted and open resections in Crohn's disease.
    Hildebrandt U; Kessler K; Pistorius G; Lindemann W; Ecker KW; Feifel G; Menger MD
    Dis Colon Rectum; 1999 Nov; 42(11):1480-6. PubMed ID: 10566539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.
    Middel P; Reich K; Polzien F; Blaschke V; Hemmerlein B; Herms J; Korabiowska M; Radzun HJ
    Gut; 2001 Dec; 49(6):795-803. PubMed ID: 11709514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.
    Harbord MW; Marks DJ; Forbes A; Bloom SL; Day RM; Segal AW
    Aliment Pharmacol Ther; 2006 Aug; 24(4):651-60. PubMed ID: 16907898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.
    Mahida YR; Ceska M; Effenberger F; Kurlak L; Lindley I; Hawkey CJ
    Clin Sci (Lond); 1992 Mar; 82(3):273-5. PubMed ID: 1312411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS
    Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease.
    Arnott ID; Drummond HE; Ghosh S
    Scott Med J; 2001 Oct; 46(5):136-9. PubMed ID: 11771492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
    Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
    Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.